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Background and aims: Esophageal squamous cell carcinoma (ESCC) is the dominant his-
tological type of esophageal cancer worldwide (90%). We aimed to provide an update of the 
global temporal trends in the incidence of ESCC.
Methods: Incidence data for ESCC were collected from 30 well-established cancer registries 
from 20 countries in Europe, Northern America, Australia, or Asia for 1970–2015. Time trends 
in annual age-standardized incidence rates of ESCC were assessed using joinpoint analysis and 
log-linear regression. Age–period–cohort analysis was used to estimate the influence of age, 
calendar-period, and birth-cohort on the observed time trends in incidence.
Results: The age-standardized incidence rates of ESCC varied more than eightfold in men and 
sevenfold in women across populations. In 2012, the highest rate of ESCC in men was observed 
in Nagasaki, Japan (9.7/100,000 person-years) and in women in Scotland (2.7/100,000 person-
years). In men, the incidence decreased globally during the study period, as well as during the 
last few years. In women, the incidence increased in Japan (three regions), the Netherlands, 
New Zealand, Norway, and Switzerland, whereas it stabilized or decreased in other populations. 
Among ethnic groups in the United States, black men and women had more pronounced decreases 
in incidence than other groups. Generally, birth-cohort effects were stronger determinants of 
incidence trends than calendar-period effects.
Conclusion: In men, the global ESCC incidence has decreased over time. In women, the inci-
dence trends vary across populations, and the rates have increased in some countries. Changes 
in the prevalence of tobacco smoking and alcohol consumption may have contributed to these 
time trends.
Keywords: esophageal cancer, esophageal neoplasm, occurrence, worldwide, epidemiology
Introduction
Esophageal cancer is the sixth leading cause of cancer-related death globally, accounting 
for 440,000 deaths in 2013.1 Esophageal squamous cell carcinoma (ESCC) represents 
90% of all cases of esophageal cancer worldwide.2,3 The main risk factors for ESCC 
are tobacco smoking and overconsumption of alcohol, particularly in combination.3 
In 2012, the estimated age-standardized incidence rate was <5/100,000 person-years 
in both sexes in most Western countries, whereas it was >13/100,000 person-years in 
men and >4/100,000 person-years in women in Eastern and Southeast Asian coun-
tries.2 In an analysis of a few Asian countries up to the year 2007, the ESCC incidence 
was decreasing in Hong Kong, Israel, and Singapore, and stable in Japan.4 Studies of 
Western populations have found linear declines in the incidence of ESCC in Australia, 
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Sweden, and the United States in 1984–2008,5 and decreasing 
or stable incidence trends in European men, but increasing 
trends in women from Austria, Denmark, Estonia, Slovakia, 
and Switzerland, in 1980–2002.6 However, recent global time 
trends have not been assessed. With the collection of the most 
updated incidence data from well-established cancer regis-
tries across the world, this study aimed to assess the recent 
global time trends in the incidence of ESCC.
Methods
Design
Data were retrieved from 30 population-based cancer reg-
istries in 20 countries during January 1, 1970 to December 
31, 2015 (varying across registries). All included registries 
have been evaluated for high completeness and quality of the 
data recorded.7 Cancer registries with incomplete histologi-
cal information for esophageal cancer were excluded. The 
requested variables were the number of newly diagnosed 
ESCCs, calendar year of diagnosis, age at diagnosis (in 
5-year groups), sex, and size of the background population 
at risk. The registries represented the following populations 
(in alphabetical order): Australia (Australian Capital Ter-
ritory, New South Wales, South Australia, Tasmania, and 
Western Australia), China (Hong Kong), Croatia (nation-
wide), Finland (nationwide), France (Calvados), Iceland 
(nationwide), Ireland (nationwide), Italy (Veneto), Japan 
(Hiroshima, Miyagi, and Nagasaki), Kuwait (nationwide), 
Netherlands (nationwide), New Zealand (nationwide), Nor-
way (nationwide), Slovenia (nationwide), Spain (Asturias, 
Granada, and Tarragona), Sweden (nationwide), Switzerland 
(almost nationwide), Thailand (Chiang Mai), United Kingdom 
(England, Scotland, and Wales), and United States (the Sur-
veillance, Epidemiology and End Results [SEER] program). 
To assess the incidence time trends in the United States, 
including ethnicity-specific data, two combinations of the 
SEER registries were used: the SEER 9 registries (including 
the states Atlanta, Connecticut, Detroit, Hawaii, Iowa, New 
Mexico, San Francisco-Oakland, Seattle-Puget Sound, and 
Utah), with the longest registration period, and the SEER 18 
registries (including all states in the SEER 9 registries plus 
the Alaska Native Tumor Registry, Greater California, Greater 
Georgia, Kentucky, Los Angeles, Louisiana, New Jersey, 
Rural Georgia, and San Jose-Monterey), with the widest 
geographic coverage.8,9 Data from the SEER registries were 
extracted from the SEER*Stat software version 8.3.3. Data 
from all other registries were collected by directly contacting 
the specific registries (contact persons are listed in Acknowl-
edgments). Cancer registries that did not reply despite several 
attempts were mostly from developing countries. Data col-
lected before 1970 were excluded to minimize differences in 
diagnosis coding practices between registries and, thus, make 
the results comparable across registries. In most registries, 
the diagnosis code C15 in the International Classification of 
Diseases, version 10 (ICD-10) defined the esophageal tumor 
site, and the histology codes 8050-8078 and 8083-8084 in 
the International Classification of Disease for Oncology, 
version 3 (ICD-O-3) represented squamous cell carcinoma. 
Detailed information about the registries included as well as 
coding of ESCC is presented in Table S1. Ethical approval and 
informed consent from participants were exempted because no 
personal records were accessed, and the study was based only 
on publicly available data of population sizes and aggregated 
data of cancer cases.
statistical analysis
All analyses were stratified for sex. Data from regional 
registries within a country were merged to provide a wider 
geographic coverage and better statistical precision. Cross-
sectional analysis comparing several registries was conducted 
for 2012, which was the most recent year of data availability 
in the majority of registries. The country-specific age-
standardized annual incidence rates were calculated using 
the direct method, based on the World Standard Population 
2000 as the reference, and the corresponding 95% CIs were 
estimated using the gamma distribution. Joinpoint analysis 
was conducted to identify change points in incidence trends, 
and to estimate the annual percentage change in each time 
segment before and after joinpoints. The annual percentage 
change was estimated on a log-linear scale under the assump-
tion that the rate changed by a constant percentage every year 
on a log-scale within a specific time-period. The average 
annual percentage change – a weighted average of annual 
percentage changes from joinpoint models with weights equal 
to the length of each segment – was computed as a summary 
measure of the trend over the study period. A maximum of 
three predefined change points were allowed. Subgroup 
analyses by ethnicity (white, black, Asian/Pacific Islander, 
and American Indian/Alaska Native) were conducted on the 
basis of the SEER registries in the United States.
Age–period–cohort regression was used to evaluate 
the effects of age, calendar-period, and birth-cohort on the 
incidence rates of ESCC, using a web-tool developed by 
the National Cancer Institute in the United States.10 Period 
effects result from factors that affect all age groups equally at 
a particular calendar time (eg, introduction of new diagnostic 
methods in a certain calendar period), whereas cohort effects 
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occur when the effect of an exposure is different across age 
groups (birth cohorts) in a certain period and are more likely 
to be associated with risk factors (eg, increased smoking 
prevalence in younger generations).The age–period–cohort 
modeling was applied with 5-year age groups (varying 
across registries), 5-year calendar-periods (varying across 
countries), and consequently spanned into partially overlap-
ping 9-year birth-cohorts. The age–period–cohort regression 
was based on a log-linear model for the incidence rates with 
additive effects from age, calendar-period, and birth-cohort 
as shown in the formula:
r
pa
= a
a
+b
p
+g
c
where r
pa
 defines the expected incidence rate, and a
a
, b
p
, and g
c
represent the effects of age, calendar-period, and birth-cohort, 
respectively. The generic effects can be separated into lin-
ear and nonlinear components. The web tool used fits the 
age–period–cohort model, and estimates the sum of linear 
components of birth-cohort and calendar-period effects (net 
drift), which is equivalent to the overall annual percentage 
change in age-standardized rates. The age-group–specific 
annual percentage change (local drift) was generated from the 
log-linear regression analysis. The relative rate in any given 
calendar-period (or birth-cohort) versus a reference calendar-
period (or birth-cohort) was estimated with adjustment for age 
and nonlinear birth-cohort effects (or calendar-period effects).
The statistical software used was mainly SAS version 9.4 
(SAS Institute, Cary, NC, USA), together with the Joinpoint 
Program (version 4.4.0.0, National Cancer Institute, United 
States) and the age–period–cohort web tool. All statistical 
tests were two-sided.
Table 1 results from joinpoint analyses for selected registers
Sex Registry Joinpoint (95% CI) Period Annual percentage change (95% CI)
Men
Croatia 2004 (2001, 2007) 1999–2004 1.9 (−3.4, 7.5)
2004–2014
−4.5 (−6.3, −2.7)
England 1997 (1996, 1999) 1990–1997 2.9 (2.1, 3.8)
1997–2014
−0.7 (−0.9, −0.5)
France (Calvados) 1986 (1980, 1994) 1978–1986
−1.1 (−5.5, 3.4)
1986–2013
−5.1 (−5.8, −4.4)
Japan (three regions) 2005 (1999, 2008) 1986–2005 1.0 (0.5, 1.6)
2005–2010
−3.1 (−7.2, 1.1)
norway 1988 (1980, 1994) 1970–1988 0.8 (−0.7, 2.2)
1988–2014
−2.2 (−3.0, −1.3)
scotland 1981 (1977, 2003) 1975–1981 4.8 (1.2, 8.5)
2000 (1995, 2007) 1981–2000 1.0 (0.4, 1.7)
2000–2014
−2.6 (−3.5, −1.6)
sweden 1987 (1983, 1990) 1970–1987 1.3 (0.3, 2.3)
1987–2015
−2.1 (−2.6, −1.6)
switzerland 1988 (1987, 1994) 1985–1988 9.6 (−3.6, 24.5)
1989–2012
−1.3 (−1.8, −0.7)
The Unites states (sEEr 9) 1986 (1983, 1989) 1973–1986
−0.4 (−1.2, 0.5)
1986–2013
−3.8 (−4.1, −3.5)
Women
England 1999 (1993, 2001) 1990–1999 2.6 (1.5, 3.7)
1999–2014
−0.9 (−1.4, −0.4)
The netherlands 1991 (1991, 1996) 1989–1991 15.8 (−9.2, 47.8)
1991–2014 0.2 (−0.3, 0.8)
norway 1987 (1972, 1999) 1970–1987 2.8 (1.1, 4.5)
1987–2014
−0.6 (−1.4, 0.3)
scotland 1993 (1990, 1997) 1975–1993 2.4 (1.5, 3.2)
1993–2014
−1.3 (−2.0, −0.6)
The Unites states (sEEr 9) 1986 (1982, 1989) 1973–1986 0.7 (−0.6, 2.0)
1986–2013
−2.9 (−3.3, −2.5)
Abbreviation: sEEr, The surveillance, Epidemiology and End results.
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Results
Participants
The study included 180,395 patients diagnosed with ESCC 
from 30 registries in 20 countries in 1970–2015. Of these, 
109,630 (60.8%) were men and 70,765 (39.2%) were women. 
The median age at diagnosis was 67.5 years (interquartile 
range 62.5–77.5 years).
incidence in 2012
In men, the highest incidence rates in the year 2012 were 
observed in Nagasaki, Japan (9.7/100,000 person-years), 
Calvados, France (8.2/100,000 person-years), and Hong 
Kong, China (4.9/100,000 person-years), whereas the lowest 
rates were found in Finland and South Australia in Australia 
(both 1.2/100,000 person-years).
In women, the incidence rates in 2012 were gener-
ally lower than in men, with the highest rates in Scotland 
(2.7/100,000 person-years), Ireland (2.6/100,000 person-
years), and Tasmania, Australia (2.0/100,000 person-years), 
and the lowest rates in Croatia, Spain (three regions) and 
Thailand (Chiang Mai; all 0.4/100,000 person-years).
The male-to-female ratio in 2012 was highest in Naga-
saki, Japan (8.9:1) and Calvados, France (8.1:1), and lowest 
in Ireland (1.0:1) and South Australia, Australia (1.1:1).
Incidence trends in 1970–2015
In men, the incidence of ESCC decreased from 2000 onwards 
in most countries, except in Japan (three regions); however, 
the year when the decrease began varied across countries 
(Figure 1A). In 1990–2014, the incidence rate was gradually 
decreasing and relatively low (<4.0/100,000 person-years) in 
North-Western European countries (Finland, Ireland, Nor-
way, the Netherlands, Sweden, Switzerland, and the United 
Kingdom [three regions]), Oceanian countries (Australia 
[five regions] and New Zealand), and the United States 
(SEER 9; Figure 1A). A sharp decrease was observed in 
Calvados, France (from 28.6/100,000 person-years in 1979 
to 6.4/100,000 person-years in 2013) and Hong Kong, China 
(from 10.1/100,000 person-years in 1994 to 5.0/100,000 
person-years in 2013; Figure 1A). In contrast, the incidence 
increased by 1.0% (95% CI 0.5%–1.6%) annually in Japan 
(three regions) in 1986–2005, followed by a slight decrease 
in 2006–2010 (Figures 1A and 2A, and Table 1).
In women, the incidence trends increased, stabilized, 
or decreased, based on the country (Figure 1B). Increasing 
incidence trends were observed in Japan (three regions), 
the Netherlands, New Zealand, Norway, and Switzerland 
throughout the study period (Figures 1B and 2B). In the 
Netherlands and Spain (three regions), an annual increase 
of >1.0% was identified during the study period. Joinpoints 
were found in the incidence trends both in the Netherlands 
and Norway in the 1990s; after the joinpoint, the incidence 
slightly increased in the Netherlands (annual percentage 
change 0.2%, 95% CI −0.3% to 0.8%), and was stable in 
Norway (annual percentage change −0.6%, 95% CI −1.4% 
to 0.3%; Table 1). In contrast to most other countries, Hong 
Kong, China, and Finland showed strongly decreasing 
incidence rates (average annual percentage change −4.0%, 
95% CI −4.9% to −3.1% and −3.7%, 95% CI −4.2% to 
−3.1%, respectively; Figure 2B). The incidence rates were 
low (<1.5/100,000 person-years) in South European coun-
tries (Croatia, France [Calvados], Italy [Veneto], Slovenia, 
and Spain [three regions]) and were stable or slightly 
increasing over time, whereas the relatively high-incidence 
countries Ireland and the United Kingdom (three regions; 
>2.0/100,000 person-years) had slightly decreasing inci-
dence rates over time (Figure 1B).
The male-to-female ratio ranged from 1.0:1 to 4.0:1 by 
country, and was stable over time in North-Western Euro-
pean countries, Oceanian countries, and the United States 
(Figure S1). In Asian (China [Hong Kong], Japan [three 
regions], and Thailand [Chiang Mai]) and South European 
countries (Croatia, France [three regions], Italy [Veneto], 
Slovenia, and Spain [three regions]), the male-to-female 
ratio ranged from 5.0:1 to 30.0:1, but decreased over time 
(Figure S1).
age–period–cohort analysis
In men, interactions between calendar-period and birth-
cohort effects seem to have contributed to the decrease in 
incidence of ESCC (Table S2). The increase in incidence 
trends in Japanese men showed a calendar-period effect 
(P=0.021), but no birth-cohort effect (P=0.059; Table S2). 
The analysis of age-specific percentage change indicated 
calendar-period effects in French men older than 50 years 
and Chinese men older than 40 years (Figure 3). Substantial 
birth-cohort effects were found in New Zealand (P=0.045) 
and Spain (three regions; P=0.004; Table S2).
In women, the incidence trends of ESCC seem to have 
been influenced by both calendar-period and birth-cohort 
effects in most countries, including Australia (five regions), 
Croatia, Finland, Slovenia, Sweden, the United Kingdom 
(three regions), and the United States (SEER 9; Table S2). 
However, the increasing incidence in Norwegian women 
was due to a calendar-period effect (P=0.046), especially in 
women aged 45–70 years (Table S2, Figure 3). A  birth-cohort 
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Figure 1 global annual age-standardized incidence rates of esophageal squamous cell carcinoma in men (A) and women (B).
Abbreviation: sEEr, The surveillance, Epidemiology and End results.
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effect was indicated behind the increasing incidence in the 
Netherlands (P<0.001), Switzerland (P=0.014), and Japan 
(three regions; P<0.001; Table S2). An increased annual 
percentage change was found in women older than 60 
years in the  Netherlands and Switzerland, and in women 
aged 45–64 years in Japan (three regions; Figure 3). The 
birth-cohort-specific relative risk was >1 in Japan (three 
regions) and Norway in recent cohorts compared with the 
reference cohort, but <1 in the Netherlands and Switzerland 
(Figure S2).
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Figure 2 average annual percentage change and 95% Ci in the incidence of esophageal squamous cell carcinoma in men (A) and women (B).
Abbreviation: sEEr, The surveillance, Epidemiology and End results.
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Ethnicity
The incidence of ESCC in the United States (SEER 9 and 18) 
was higher in black men and women than in white, Asian, 
Pacific Islander, American Indian, or Alaska Native groups 
(Figure 4A).
In men, the incidence in blacks increased from the year 
1973 and peaked in 1986 (17.8/100,000 person-years), fol-
lowed by a steady decrease to 3.6/100,000 person-years in 
2013. In white, Pacific, or Alaskan men, low incidence rates 
(<3.0/100,000 person-years) in the 1970s were followed 
by a further slight decrease throughout the study period 
(Figure 4A).
In women, black women had an incidence rate of 
1.4/100,000 person-years and white and Pacific or Alaskan 
women had an incidence of 0.5/100,000 person-years in 
2013 (Figure 4B). A relatively high incidence was found 
in black women in 1977–1992, peaking in the year 1981 at 
5.6/100,000 person-years, and declining from 1993 onwards. 
In white and Pacific or Alaskan women, the incidence was 
low and continued to slightly decrease during the study 
period (Figure 4B).
Discussion
This global assessment of the recent incidence trends of 
ESCC showed a generally decreasing incidence in men during 
the last decade, although it is still high in some populations, 
including Japan (three regions), France (Calvados), and China 
(Hong Kong). The incidence is generally lower in women 
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Figure 3 Age-specific annual percentage change (local drifts) in the incidence of esophageal squamous cell carcinoma stratified by sex.
Note: aData from England and scotland were merged and analyzed for the United Kingdom.
Abbreviation: sEEr, The surveillance, Epidemiology and End results.
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than in men, but some countries have increased incidence 
in women – that is, Japan (three regions), the Netherlands, 
New Zealand, Norway, and Switzerland. The incidence has 
decreased more rapidly in blacks than in other ethnicities in 
the United States.
A decreasing incidence of ESCC globally in men has 
been reported previously,6,11–19 and the present study indicated 
a continuous decrease during recent years. A study using 
incidence data from 12 countries in 1988–2007 predicted 
a continuing decrease in the incidence of ESCC in men 
worldwide, except in Japan, and increasing trends in women 
in Japan, the Netherlands, Slovakia, and Spain.20 That predic-
tion is supported by the updated results of the present study. 
Increased incidence trends in men have been reported in 
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Figure 4 age-standardized incidence rates of esophageal squamous cell carcinoma in the United states by ethnicity in men (A) and women (B).
Abbreviation: sEEr, The surveillance, Epidemiology and End results.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Clinical Epidemiology 2018:10submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
726
Wang et al
England, the Netherlands, Scotland, and the Nordic countries 
during the 1980s–1990s;6,15,16,21 however, the present study 
shows that the incidence decreased after the 2000s in these 
countries. In women, previous studies have reported stable or 
slightly increasing incidence rates in France, Italy, Norway, 
Slovenia, and Switzerland before the 2000s,6,11,12,16,19 and 
these trends continued in 2005–2015 in the present study. 
A slightly increasing incidence has been reported in Swed-
ish and Scottish women in 1980–1997;15 however, after this 
period, the incidence has continued to decrease.
The increasing incidence of ESCC in women in some 
countries deserves attention. Increased use of endoscopy 
and improved registration systems might have resulted in an 
artificially increased incidence due to earlier tumor detection, 
but it is unlikely that these factors differ between the sexes. 
Tumor misclassification should be limited and misclassifica-
tion of ESCC with adenocarcinoma should be uncommon; the 
proportion of esophageal tumors with unspecified histology 
was <20% in almost all registries. Calendar-period effects 
were found in women in Norway, whereas birth-cohort 
effects were found in women in Japan, the Netherlands, and 
Switzerland and could have contributed to the increase. The 
age–period–cohort analysis indicated that the increasing 
incidence in women from Japan and Norway could continue 
during the coming decades, whereas the incidence in Dutch 
and Swiss women could decline. Additionally, changes in 
the prevalence of risk factor exposure may influence the 
increasing incidence rates in women in some countries. An 
increased prevalence of smoking has been reported in Swiss 
women (from 20.6% in 1980 to 26.1% in 1998), which 
could explain the increasing incidence until 2012, but this 
trend might change due to the sharp drop in tobacco smok-
ing after 1998.22 Dutch women have had a slight increase in 
smoking prevalence (from 23.4% to 25.9% in 1980–1990), 
and a moderate decrease after 1990, which corresponds to 
the increasing incidence of ESCC reported in the present 
study and a predicted future decreasing trend.22 However, the 
increased incidence in Japanese women does not correspond 
with the stable prevalence of tobacco smoking (11.0–12.0% 
in 1980–2005).22 On the other hand, the prevalence of alcohol 
consumption among Japanese women increased from 6.3% to 
9.4% in 1989–1998,23 which could contribute to the increase, 
particularly because the use of spirits, which is a stronger risk 
factor for ESCC than other alcoholic beverages, composed 
almost half of the total alcohol consumption in Japan.24 In 
Norwegian women, the tobacco smoking prevalence was 
stable at 27.0% in 1980–1991 and decreased to 15.9% in 
2010,22 and the alcohol consumption has remained stable,25 
indicating a role for other factors in explaining the increasing 
incidence of ESCC.
The generally decreasing incidence trends of ESCC in 
men from around the 1990s onwards could be explained 
by the globally declining smoking prevalence in men since 
1980.22,26 Additionally, the trends in alcohol consumption 
have been decreasing or stable from 1980s onwards.27,28 The 
increasing incidence of ESCC in Japan over time before 2005 
is in contrast to the decreasing smoking prevalence,22,23 but 
can be explained by the increasing prevalence of alcohol 
consumption.28
The higher incidence of ESCC in black men than in 
other ethnicities in the United States could be explained by 
the higher smoking prevalence compared with other ethnici-
ties.29 The decreasing incidence in all ethnicities assessed 
is in accordance with the declining smoking prevalence in 
the United States.22 However, in black women, the smoking 
prevalence is similar to that of white women and the alcohol 
consumption is lower.30 The distinct incidence time trends 
among women of different ethnic groups might be explained 
by other factors (eg, diet).31,32
To the best of our knowledge, this is the most comprehen-
sive and updated study examining the global incidence trends 
of ESCC. Strengths include the direct data collection from 
cancer registries of high quality and completeness.7 More-
over, the age–period–cohort analysis enabled assessment of 
calendar-period-specific and birth-cohort-specific effects. 
The lack of nationwide registries in some included countries 
is among the limitations of this study. Therefore, merging of 
data from regional registries within the same country was 
applied. The fact that the registries covered entire countries 
or large regions meant that we could not separate rural and 
urban areas. Another limitation was that data on histological 
tumor type was not accessible from China, except for Hong 
Kong. The lack of individual data from cancer registries 
on risk factors (eg, regarding tobacco smoking and alcohol 
consumption) prohibited direct analyses of potential reasons 
for the observed change in incidence trends of ESCC, which 
however were indirectly analyzed and indicated by the age–
period–cohort model in the study.
Monitoring the incidence trends of ESCC is of importance 
for future research and may have public health implications. 
Tobacco control activities have contributed to the decreasing 
incidence trends of ESCC in several countries (eg, in Hong 
Kong, the United States, and several European countries).4,14,33 
However, more efforts toward alcohol control are proposed, 
not least in Eastern countries, including Japan.28 Despite the 
decreasing incidence of ESCC in most countries, the inci-
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dence remains high in many populations, and the increasing 
incidence in women in some countries is worrisome.3
Conclusion
The global incidence of ESCC is decreasing in men, but 
increasing in women in Japan (three regions), the Nether-
lands, New Zealand, Norway, and Switzerland. An emphasis 
on continuous monitoring of the changing epidemiology of 
ESCC and prioritization of primary prevention of risk factors, 
including tobacco and alcohol control, is recommended in 
several populations, not least in women.
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